Skip to NavigationSkip to content

InPharm - UK News

Cites lack of evidence for blood disorder drug's health benefits 
Use of Tyverb restricted to clinical trials
Andrew Lansley
In first speech as health secretary says he wants more joined-up working between hospitals and community services
Will offer support service to prevent vascular disease within the NHS Health Check programme
Too expensive for benefits, says UK cost effectiveness body
Celgene's multiple myeloma treatment put ahead of rival
Oral formulation simplifies treatment for patients
Bayer cross
Nexavar deemed too costly despite company’s patient access scheme
Monitor will become a full economic regulator for the health service as part of the changes
MMR website
GMC said a 1998 study that linked the MMR vaccine with autism was conducted 'dishonestly and irresponsibly'
a site by SiftGroups